PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 95 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,585,198 | -10.6% | 1,310,048 | +23.5% | 0.21% | -0.5% |
| Q2 2023 | $15,187,864 | +284.1% | 1,060,605 | +91.5% | 0.21% | +215.2% |
| Q1 2023 | $3,954,339 | -36.1% | 553,829 | +0.4% | 0.07% | -42.6% |
| Q4 2022 | $6,191,499 | +1.2% | 551,827 | -0.1% | 0.12% | +7.5% |
| Q3 2022 | $6,121,000 | +30.4% | 552,442 | -0.7% | 0.11% | +27.4% |
| Q2 2022 | $4,694,000 | -38.0% | 556,105 | -0.0% | 0.08% | +20.0% |
| Q1 2022 | $7,571,000 | -29.5% | 556,293 | +1.9% | 0.07% | +14.8% |
| Q4 2021 | $10,741,000 | -39.2% | 546,055 | -0.8% | 0.06% | -33.7% |
| Q3 2021 | $17,663,000 | -4.5% | 550,240 | +0.7% | 0.09% | +1.1% |
| Q2 2021 | $18,500,000 | -39.8% | 546,522 | -33.2% | 0.09% | -45.2% |
| Q1 2021 | $30,739,000 | – | 818,385 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |